 Surgical chemotherapeutic treatment hepatic metastases carcinoma breast date year survival rates patients hepatic metastases HM breast origin chemotherapy hormone therapy study surgical excision metastatic disease chemotherapy effect poor prognosis Between May September patients diagnosis isolated solitary multiple therapeutic approach systemic preoperative postoperative chemotherapy Laparotomy findings patients benign hepatic lesions patients different histologic types hepatectomy patients Diffuse metastatic disease attempt hepatic resection patients Hepatectomy possible patients postoperative mortality minimal morbidity One-half patients metastases positive lymph nodes hepatic pedicule Median survival time patients hepatectomy months hepatectomy months discovery HM Eleven patients metastases average period months hepatectomy liver first site recurrence patient underwent hepatectomy patients free disease months spite poor prognostic features excised specimen median survival time times usual treatment procedure doubtful benefit situation hepatectomy acts cytoreductive surgical treatment main limiting factor low effectiveness chemotherapy type therapy restricted number patients study protocol chemotherapy